SHENZHEN, China, March 7, 2014 /PRNewswire/ -- Mindray Medical
International Limited ("Mindray", NYSE: MR), a leading developer,
manufacturer, and marketer of medical devices worldwide, announced
today that, in accordance with NYSE rules, holders of record of
Mindray ADSs at the close of business on March 14, 2014 are entitled to the recently
declared dividend ($0.50 per ordinary
share). Each Mindray ADS corresponds to one ordinary share. The
record date for Mindray's ordinary shares (previously announced as
March 8, 2014) will also be
March 14, 2014.
The dividend payment date will continue to be on or around
April 8, 2014. Dividends to be paid
to Mindray's ADS holders through the depositary bank will be
subject to the terms of the deposit agreement, including the fees
and expenses payable thereunder.
About Mindray
We are a leading developer, manufacturer, and marketer of
medical devices worldwide. We maintain our global headquarters
in Shenzhen, China, U.S.
headquarters in Mahwah, New Jersey and multiple sales
offices in major international markets. From our main manufacturing
and engineering base in China, we supply through our worldwide
distribution network a broad range of products across three primary
business segments, namely patient monitoring and life support,
in-vitro diagnostic, and medical imaging systems. For more
information, please visit http://ir.mindray.com.
For investor and media inquiries, please contact:
In China:
Cathy Gao
Mindray Medical International Limited
Tel: +86-755-8188-8023
Email: cathy.gao@mindray.com
In the U.S:
Hoki Luk
Western Bridge, LLC
Tel: +1-646-808-9150
Email: hoki.luk@westernbridgegroup.com
SOURCE Mindray Medical International Limited